XBiotech Inc.

XBIT | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.18

-$0.01 (-0.46%)

At close: Sep 21, 2026, 4:00 PM ET

$2.18

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.46%

(1D)

Rating

Updated: Aug 21, 2026

20.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $66.46M

1D Range

2.17 2.20

52W Range

2.09 3.44

Valuation (TTM)

PE -1.47

PB 0.52

EV/EBITDA 1.00

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target N/A

Cash Flow

FCF Yield -61.4%

SBC Adj. FCF Yield -62.2%

SBC Impact -1.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -92.4%

Dil EPS 3Y | 5Y -13.9% | -10.9%

FCF 3Y | 5Y -26.9% | -24.9%

Returns

ROA -33.8%

ROE -31.6%

ROIC -37.0%

Financial Health

Net Cash

$109.53M

Current Ratio 33.15

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline...

Sector Healthcare

Industry Biotechnology

Employees 87

IPO Date Apr 14, 2015

Website www.xbiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.